Latest News
Grifols partners with BARDA to develop treatment for sulfur mustard eye injury
22 October 2024 - Spanish healthcare company Grifols (MCE:GRF) (MCE:GRF.P) (NASDAQ:GRFS), a manufacturer of plasma-derived medicines, announced on Tuesday that it has partnered with the Biomedical Advanced Research and Development Authority (BARDA) t...
Camurus receives complete response letter for CAM2029 NDA
22 October 2024 - Swedish biopharmaceutical company Camurus AB (STO:CAMX) reported on Tuesday that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the new drug application (NDA) for CAM2029 (octreotide)...
Swedish AI Medical Technologies to begin trial for AI melanoma diagnostic tool
22 October 2024 - Let'em know AB announced on Tuesday that Swedish AI Medical Technologies has received approval to initiate a clinical trial focused on Dermalyser, its AI-driven diagnostic support tool for melanoma assessment.This investor-led,...
Adcentrx Therapeutics' ADRX-0405 IND application approved by US FDA
22 October 2024 - California-based clinical-stage biotechnology company Adcentrx Therapeutics announced on Monday that it has received approval from the US Food and Drug Administration (FDA) for the company's Investigational New Drug (IND) appli...
Nanoscope Therapeutics publishes findings that MCO-010 optogenetic treatment arrests further retinal degeneration
22 October 2024 - Texas-based, late-stage clinical biotechnology company Nanoscope Therapeutics Inc on Monday announced a breakthrough discovery in Translational Vision Science & Technology (TVST, an ARVO journal) demonstrating that MCO-010 optog...